Cite
HARVARD Citation
Mosqueira, D. et al. (2018). CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy. European heart journal. pp. 3879-3892. [Online].